$HRMY 3 SEC Filings

Filed On	Filing
22 Jul 2026	Form 3: Mollichella Stephen M., INT PRINCIAL FINANCIAL OFFICER Holds 2,506 shares of Common Stock
18 May 2026	Form 3: Germano Geno J, Director No securities owned
18 May 2026	Form 3: Reicin Glenn, CHIEF FINANCIAL OFFICER No securities owned
06 Apr 2026	Form 3: Ignelzi Troy A., Director No securities owned
16 Apr 2025	Form 3: Zaeske Adam H., CHIEF COMMERCIAL OFFICER No securities owned
04 Apr 2025	Form 3: Philip Ron M, Director No securities owned
26 Jan 2024	Form 3: Budur Kumar, CHIEF MEDICAL OFFICER Holds 1,005 shares of Common Stock
08 Nov 2023	Form 3: Anastasiou Peter, Director No securities owned
29 Nov 2021	Form 3: Szyper Linda M, Director No securities owned
31 Mar 2021	Form 3: Kapadia Sandip, Chief Financial Officer No securities owned
13 Nov 2020	Form 3: Motley Eric L, Director No securities owned
13 Nov 2020	Form 3: Graf R. Mark, Director No securities owned
18 Aug 2020	Form 3: Valor Iv Pharma Holdings, Llc, 10% owner and 2 others Holds 845,336 shares of Common Stock
18 Aug 2020	Form 3: Nielsen Jack, Director
18 Aug 2020	Form 3: Serafin Andrew, Chief Business Officer
18 Aug 2020	Form 3: Marshman Fund Trust Ii, 10% owner Holds 6,931,763 shares of Common Stock
18 Aug 2020	Form 3: Jacobs John C, Director
18 Aug 2020	Form 3: Dayno Jeffrey M., Chief Medical Officer
18 Aug 2020	Form 3: Sender Gary, Director No securities owned
18 Aug 2020	Form 3: Drexler Susan L., Chief Financial Officer

Comments